Results

Latest quarterly results

Companies that reported quarterly results recently, newest first. Each row compares the reported quarter with the same quarter a year earlier. Figures in USD; revenue and net income in millions.

878 companies in Healthcare reported in the last 30 days · showing 451–500 · updated Wed, Nov 18, 2026

CompanySectorReportedQuarter RevenueRev. YoYNet incomeNI YoYEPSEPS YoY Op. marginMargin chg.Market cap
TELOTelomir Pharmaceuticals, Inc. Healthcare Nov 6 Sep '26 $0.0M n/m −$1.0M n/m −$0.01 n/m — — $31M
IGCIGC Pharma, Inc. Healthcare Nov 6 Sep '26pending $0.3M† n/m — — — — — — $22M
BIAFbioAffinity Technologies, Inc. Healthcare Nov 6 Sep '26 $1.0M 0.0% −$5.0M n/m −$5.89 n/m -328.0% −169.4 pp $12M
BIVIBioVie Inc. Healthcare Nov 6 Sep '26 $0.0M n/m −$6.0M n/m −$0.68 n/m — — $11M
ALGSAligos Therapeutics, Inc. Healthcare Nov 6 Sep '26 $3.0M +200.0% −$22.0M n/m −$2.09 n/m -763.0% — $8M
SNGXSoligenix, Inc. Healthcare Nov 6 Sep '26 $0.0M n/m −$1.0M n/m −$0.05 n/m — — $7M
CDIOCardio Diagnostics Holdings Inc. Healthcare Nov 6 Sep '26 $0.0M n/m −$2.0M n/m −$0.59 n/m — — $5M
CELZCreative Medical Technology Holdings, Inc. Healthcare Nov 6 Sep '26 $0.0M n/m −$3.0M n/m −$0.40 n/m — — $4M
ERNAErnexa Therapeutics Inc. Healthcare Nov 6 Sep '26 $0.0M n/m −$3.0M n/m −$1.89 n/m — — $3M
MBIOMustang Bio, Inc. Healthcare Nov 6 Sep '26 $0.0M n/m −$1.0M n/m −$0.14 n/m — — $3M
MDCXMedicus Pharma Ltd. Healthcare Nov 6 Sep '26 $0.0M n/m −$15.0M n/m −$11.64 n/m — — $2M
CIThe Cigna Group Healthcare Nov 5 Sep '26 $73.68B +5.6% $1.44B −22.8% $5.47 −21.5% 3.3% −0.5 pp $77.5B
CAHCardinal Health, Inc. Healthcare Nov 5 Sep '26 $67.51B +5.5% $554M +23.1% $2.38 +26.6% 1.1% +0.1 pp $64.5B
BDXBecton, Dickinson and Company Healthcare Nov 5 Sep '26 $5.27B −10.5% $696M +41.2% $2.54 +47.7% 19.6% +7.7 pp $58.7B
NTRANatera, Inc. Healthcare Nov 5 Sep '26 $794M +34.1% −$60.0M n/m −$0.42 n/m -8.6% +7.9 pp $41.7B
MTDMettler-Toledo International, Inc. Healthcare Nov 5 Sep '26 $1.09B +6.2% $246M +13.4% $12.29 +16.3% 28.3% +0.2 pp $34.1B
ZTSZoetis Inc. Healthcare Nov 5 Sep '26 $2.39B −0.4% $591M −18.0% $1.44 −11.7% 36.1% −2.9 pp $33.9B
VTRSViatris Inc. Healthcare Nov 5 Sep '26 $3.75B −0.3% −$325M n/m −$0.28 n/m 7.0% +0.3 pp $23.4B
GHGuardant Health, Inc. Healthcare Nov 5 Sep '26 $361M +36.2% −$124M n/m −$0.93 n/m -36.8% +0.6 pp $19.4B
SOLVSolventum Corporation Healthcare Nov 5 Sep '26 $1.95B −7.0% −$12.0M −100.9% −$0.07 −101.0% 3.5% −3.0 pp $14.6B
HALOHalozyme Therapeutics, Inc. Healthcare Nov 5 Sep '26 $493M +39.3% $247M +41.1% $2.01 +40.6% 59.8% −1.7 pp $10.9B
GMEDGlobus Medical, Inc. Healthcare Nov 5 Sep '26 $764M −0.7% $141M +18.5% $1.04 +18.2% 23.3% +5.7 pp $9.3B
PTGXProtagonist Therapeutics, Inc. Healthcare Nov 5 Sep '26 $274M +5,380% $220M n/m $3.07 n/m 79.6% +1064.7 pp $8.1B
OSCROscar Health, Inc. Healthcare Nov 5 Sep '26 $5.14B +72.1% $167M n/m $0.49 n/m 3.5% +7.8 pp $7.7B
TXG10x Genomics, Inc. Healthcare Nov 5 Sep '26 $151M +1.3% −$19.0M n/m −$0.15 n/m -10.7% +11.0 pp $6.8B
LNTHLantheus Holdings, Inc. Healthcare Nov 5 Sep '26 $390M +1.6% $22.0M −21.4% $0.33 −19.5% 8.3% −3.1 pp $6.7B
TFXTeleflex Incorporated Healthcare Nov 5 Sep '26 $568M −37.8% $927M n/m $22.28 n/m 18.6% +21.8 pp $6.3B
DOCSDoximity, Inc. Healthcare Nov 5 Sep '26 $175M +3.6% $35.0M −43.5% $0.18 −41.9% 25.2% −12.6 pp $5.5B
HAEHaemonetics Corporation Healthcare Nov 5 Sep '26 $358M +9.5% $46.0M +17.9% $1.00 +23.5% 21.0% +0.5 pp $5.5B
LFSTLifeStance Health Group, Inc. Healthcare Nov 5 Sep '26 $456M +25.3% $22.0M +2,100% $0.06 n/m 7.3% +5.2 pp $5.4B
CONConcentra Group Holdings Parent, Inc. Healthcare Nov 5 Sep '26 $622M +8.6% $66.0M +37.5% $0.52 +40.5% 18.5% +2.0 pp $5.4B
ICUIICU Medical, Inc. Healthcare Nov 5 Sep '26 $560M +4.3% $27.0M n/m $1.07 n/m 9.3% +6.8 pp $4.4B
AMLXAmylyx Pharmaceuticals, Inc. Healthcare Nov 5 Sep '26 $0.0M n/m −$45.0M n/m −$0.38 n/m — — $3.5B
IOVAIovance Biotherapeutics, Inc. Healthcare Nov 5 Sep '26 $121M +80.6% −$22.0M n/m −$0.05 n/m -19.7% +113.3 pp $3.5B
ELVNEnliven Therapeutics, Inc. Healthcare Nov 5 Sep '26 $0.0M n/m −$28.0M n/m −$0.36 n/m — — $3.4B
PLSEPulse Biosciences, Inc Healthcare Nov 5 Sep '26 $0.0M n/m −$23.0M n/m −$0.32 n/m — — $3.3B
TMDXTransMedics Group, Inc. Healthcare Nov 5 Sep '26 $203M +41.0% $17.0M −29.2% $0.46 −30.3% 13.9% −2.3 pp $3.3B
PRVAPrivia Health Group, Inc. Healthcare Nov 5 Sep '26 $657M +13.3% $13.0M +85.7% $0.10 +100.0% 3.1% +0.7 pp $3.2B
GRDNGuardian Pharmacy Services, Inc. Healthcare Nov 5 Sep '26 $371M −1.6% $19.0M +90.0% $0.29 +93.3% 6.8% +2.3 pp $3.2B
XERSXeris Biopharma Holdings, Inc. Healthcare Nov 5 Sep '26 $107M +44.6% $11.0M +1,000% $0.06 n/m 15.8% +6.7 pp $3.1B
DYNDyne Therapeutics, Inc. Healthcare Nov 5 Sep '26 $0.0M n/m −$194M n/m −$1.06 n/m — — $3.0B
IRTCiRhythm Holdings, Inc. Healthcare Nov 5 Sep '26 $222M +15.0% −$30.0M n/m −$0.90 n/m -14.7% −12.6 pp $3.0B
VCELVericel Corporation Healthcare Nov 5 Sep '26 $85.0M +25.0% $14.0M +180.0% $0.27 +170.0% 14.3% +9.2 pp $3.0B
IRONDisc Medicine, Inc. Healthcare Nov 5 Sep '26 $0.0M n/m −$60.0M n/m −$1.53 n/m — — $2.9B
CELCCelcuity Inc. Healthcare Nov 5 Sep '26 $0.0M n/m −$73.0M n/m −$1.33 n/m — — $2.8B
PBHPrestige Consumer Healthcare Inc. Healthcare Nov 5 Sep '26 $336M +22.6% $25.0M −40.5% $0.53 −38.4% 24.0% −5.1 pp $2.3B
CLDXCelldex Therapeutics, Inc. Healthcare Nov 5 Sep '26 $0.0M n/m −$76.0M n/m −$0.96 n/m — — $2.2B
PVLAPalvella Therapeutics, Inc. Healthcare Nov 5 Sep '26 $0.0M n/m −$25.0M n/m −$1.70 n/m — — $2.1B
VERAVera Therapeutics, Inc. Healthcare Nov 5 Sep '26 $10.0M n/m −$94.0M n/m −$1.30 n/m -931.2% — $1.9B
ZBIOZenas BioPharma, Inc. Healthcare Nov 5 Sep '26 $10.0M n/m −$109M n/m −$1.65 n/m — — $1.9B
  • Report dates come from the earnings calendar (dates loaded Oct 4 to Dec 9); figures come from the quarterly statements stored for each company. Click a ticker for its full statements.
  • YoY compares the reported quarter with the same quarter a year earlier. n/m (not meaningful) means the year-earlier figure was zero or negative, so a percentage change would not describe it. Margin change is in percentage points.
  • pending: the company has reported, but that quarter is not in our statements yet. Revenue marked † is the announced figure from the earnings calendar; the other columns fill in once the statements update.

Data for information only, not investment advice. Figures may be delayed or inaccurate; verify against company filings. See our disclaimer.